Molecular formula: | C26H25F7N4O3 |
Average mass: | 574.497 |
Monoisotopic mass: | 574.181488 |
ChemSpider ID: | 34992153 |
3 of 3 defined stereocentres
(2R,3S)-N-[(3S)-5-(3-Fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)succinamide
[ACD/IUPAC Name](2R,3S)-N-[(3S)-5-(3-Fluorophényl)-9-méthyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazépin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)succinamide
[French]
[ACD/IUPAC Name](2R,3S)-N-[(3S)-5-(3-Fluorphenyl)-9-methyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluorpropyl)succinamid
[German]
[ACD/IUPAC Name]1584647-27-7
[RN]Butanediamide, N~1~-[(3S)-5-(3-fluorophenyl)-2,3-dihydro-9-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)-, (2R,3S)-
[ACD/Index Name]LSK1L593UU
[UNII](2R,3S)-N1-((S)-5-(3-Fluorophenyl)-9-methyl-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-2,3-bis(3,3,3-trifluoropropyl)succinamide
(2S,3R)-N′-[(3S)-5-(3-fluorophenyl)-9-methyl-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)butanediamide
Butanediamide,N1-[(3S)-5-(3-fluorophenyl)-2,3-dihydro-9-methyl-2-oxo-1H-1,4-benzodiazepin-3-yl]-2,3-bis(3,3,3-trifluoropropyl)-,(2R,3S)-
MFCD28502064
[MDL number]NOTC1_HUMAN
NOTC3_HUMAN
Notch inhibitor 1
US9273014, 1